{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:25Z","timestamp":1776329845154,"version":"3.50.1"},"reference-count":23,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.6002\/ect.2020.0023","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T09:33:31Z","timestamp":1613986411000},"page":"250-258","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Donor Transaminase Levels on Graft Survival Following Liver Transplant: An Analysis of the Organ Procurement and Transplantation Network Database"],"prefix":"10.6002","volume":"19","author":[{"given":"Ioannis A.","family":"Ziogas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophoclis P.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea K.","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A.","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Geevarghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Lee","family":"Gorden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth J.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I.","family":"Montenovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Martin P, DiMartini A, Feng S, Brown R, Jr., Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144-1165. doi:10.1002\/hep.26972","DOI":"10.1002\/hep.26972"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Kim WR, Lake JR, Smith JM, et al. OPTN\/SRTR 2017 Annual Data Report: Liver. Am J Transplant. 2019;19 Suppl 2:184-283. doi:10.1111\/ajt.15276","DOI":"10.1111\/ajt.15276"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. deLemos AS, Vagefi PA. Expanding the donor pool in liver transplantation: Extended criteria donors. Clin Liver Dis (Hoboken). 2013;2(4):156-159. doi:10.1002\/cld.222","DOI":"10.1002\/cld.222"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg. 2006;244(3):439-450. doi:10.1097\/01.sla.0000234896.18207.fa","DOI":"10.1097\/01.sla.0000234896.18207.fa"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wolf PL. Biochemical diagnosis of liver disease. Indian J Clin Biochem. 1999;14(1):59-90. doi:10.1007\/BF02869152","DOI":"10.1007\/BF02869152"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Bacchella T, Galvao FH, Jesus de Almeida JL, Figueira ER, de Moraes A, Cesar Machado MC. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J. 2008;126(3):161-165. doi:10.1590\/s1516-31802008000300005","DOI":"10.1590\/S1516-31802008000300005"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Goldaracena N, Quinonez E, Mendez P, et al. Extremely marginal liver grafts from deceased donors have outcome similar to ideal grafts. Transplant Proc. 2012;44(7):2219-2222. doi:10.1016\/j.transproceed.2012.07.113","DOI":"10.1016\/j.transproceed.2012.07.113"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Cuende N, Miranda B, Canon JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplantation. 2005;79(10):1445-1452. doi:10.1097\/01.tp.0000158877.74629.aa","DOI":"10.1097\/01.TP.0000158877.74629.AA"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783-790. doi:10.1111\/j.1600-6143.2006.01242.x","DOI":"10.1111\/j.1600-6143.2006.01242.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Martins PN, Rawson A, Movahedi B, et al. Single-center experience with liver transplant using donors with very high transaminase levels. Exp Clin Transplant. 2019;17(4):498-506. doi:10.6002\/ect.2017.0172","DOI":"10.6002\/ect.2017.0172"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Fakhar N, Nikeghbalian S, Kazemi K, et al. transplantation of deceased donor livers with elevated levels of serum transaminases at Shiraz Transplant Center. Hepat Mon. 2016;16(10):e40140. doi:10.5812\/hepatmon.40140","DOI":"10.5812\/hepatmon.40140"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Reyes J, Perkins J, Kling C, Montenovo M. Size mismatch in deceased donor liver transplantation and its impact on graft survival. Clin Transplant. 2019;33(8):e13662. doi:10.1111\/ctr.13662","DOI":"10.1111\/ctr.13662"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098. doi:10.1056\/NEJM198710223171717","DOI":"10.1056\/NEJM198710223171717"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14(12):1694-1707. doi:10.1002\/lt.21668","DOI":"10.1002\/lt.21668"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8(12):2537-2546. doi:10.1111\/j.1600-6143.2008.02400.x","DOI":"10.1111\/j.1600-6143.2008.02400.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. McCormack L, Quinonez E, Rios MM, et al. Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'. HPB (Oxford). 2010;12(8):523-530. doi:10.1111\/j.1477-2574.2010.00193.x","DOI":"10.1111\/j.1477-2574.2010.00193.x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome. Clin Gastroenterol Hepatol. 2008;6(12):1389-1395; quiz 1287. doi:10.1016\/j.cgh.2008.08.018","DOI":"10.1016\/j.cgh.2008.08.018"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Braat AE, Blok JJ, Putter H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012;12(10):2789-2796. doi:10.1111\/j.1600-6143.2012.04195.x","DOI":"10.1111\/j.1600-6143.2012.04195.x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Radunz S, Paul A, Nowak K, Treckmann JW, Saner FH, Math\u00e9 Z. Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go? Liver Int. 2011;31(7) 1021-1027. doi:10.1111\/j.1478-3231.2011.02525.x","DOI":"10.1111\/j.1478-3231.2011.02525.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Mangus RS, Fridell JA, Kubal CA, Davis JP, Tector AJ. Elevated alanine aminotransferase (ALT) in the deceased donor: impact on early post-transplant liver allograft function. Liver Int. 2015;35(2):524-531. doi:10.1111\/liv.12508","DOI":"10.1111\/liv.12508"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Flores A, Asrani SK. The donor risk index: a decade of experience. Liver Transpl. 2017;23(9):1216-1225. doi:10.1002\/lt.24799","DOI":"10.1002\/lt.24799"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Campos-Varela I, Dodge JL, Stock PG, Terrault NA. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus. Clin Transplant. 2016;30(9):1140-1145. doi:10.1111\/ctr.12800","DOI":"10.1111\/ctr.12800"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Kim DY, Moon J, Island ER, et al. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant. 2011;25(2):270-276. doi:10.1111\/j.1399-0012.2010.01222.x","DOI":"10.1111\/j.1399-0012.2010.01222.x"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T04:13:16Z","timestamp":1615954396000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2021\/19\/3\/0\/250\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0023","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}